Table 1 (abstract A82). Clinical data on liver transplant recipients detected to be colonized by MDROs. Other: Infection from a pathogen other than the one of colonization. MRSA: methicillin resistant staphylococcus aureus, KPC klebsiella pneumoniae carbapenemase, MLSb: Macrolide-lincosamide-streptogramin B, CTX-M CefoTaXime-Munich, VanA/VanB: Vancomycin resistance type A/B, OXA-48: oxacillinase-48, ICU-LOS: intensive care uniti length of stay
From: Abstracts of the ICARE 2023 77th SIAARTI National Congress
Age | Sex | Etiology | MELD | Colonization | Infection | ICU LOS | Hospital LOS |
|---|---|---|---|---|---|---|---|
73 | M | Hepatitis C-Virus | 13 | MRSA | Yes (MRSA) | 4 | 14 |
58 | F | Hepatitis B-, hepatitis D-Virus | 20 | MRSA | Yes (MRSA) | 5 | 12 |
48 | F | Primary Biliary Cholangitis | 15 | KPC, MLSb | Yes (KPC) | 3 | 16 |
45 | F | Alcohol related | 9 | CTX-M | Yes (CTX-M) | 7 | 13 |
64 | M | Hepatitis C-Virus | 6 | MLSb | No | 2 | 8 |
24 | M | Primary sclerosing cholangitis | 20 | MLSb | No | 5 | 10 |
59 | M | Hepatitis B-Virus | 10 | KPC | No | 7 | 14 |
56 | F | Hepatitis B-Virus | 8 | CTX-M | No | 6 | 12 |
58 | M | Non-alcoholic Steatohepatitis | 8 | CTX-M | No | 3 | 7 |
50 | M | Hepatitis B-Virus | 17 | CTX-M | No | 6 | 23 |
70 | M | Primary sclerosing cholangitis | 12 | CTX-M / VanA | No | 5 | 14 |
42 | M | Primary sclerosing cholangitis | 30 | OXA48, VanA, CTX-M | No | 6 | 26 |
19 | M | Primary sclerosing cholangitis | 16 | MLSb | Yes (other) | 3 | 23 |
48 | M | Hepatitis B-Virus | 7 | VanB | Yes (other) | 5 | 11 |
64 | M | Hepatitis C-Virus | 24 | CTX-M | Yes (other) | 5 | 24 |
52 | M | Caroli disease | 9 | CTX-M | Yes (other) | 3 | 24 |
62 | M | Non-alcoholic Steatohepatitis | 16 | MRSA | Yes (other | 5 | 46 |
65 | F | Hepatitis B-, hepatitis D-Virus | 11 | VanB | Yes (other) | 4 | 14 |